Financhill
Back

Franklin International Core Dividend Tilt Idx ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
70

DIVI
Franklin International Core Dividend Tilt Idx ETF

Last Price:
$39.04
Seasonality Move:
2.51%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.33
Seasonality Move:
-34.19%
Buy
70
Franklin International Core Dividend Tilt Idx ETF (DIVI) is a Buy

Is Franklin International Core Dividend Tilt Idx ETF a Buy, Sell or Hold?

  • The current Franklin International Core Dividend Tilt Idx ETF [DIVI] share price is $38.75. The Score for DIVI is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • DIVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DIVI Stock Price Chart

What is Franklin International Core Dividend Tilt Idx ETF's stock price today?

  • The Franklin International Core Dividend Tilt Idx ETF share price today is $38.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DIVI is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DIVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 54.21 Buy
Chaikin Money Flow: 124116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.7 - 39) Buy
Bollinger Bands (100): (36.7 - 38.4) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

DIVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.94 Sell
20-day SMA: 38.6 Buy
50-day SMA: 38.15 Buy
200-day SMA: 35.9 Buy
8-day EMA: 38.81 Sell
20-day EMA: 38.62 Buy
50-day EMA: 38.18 Buy
200-day EMA: 36.17 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Franklin International Core Dividend Tilt Idx ETF Earnings Growth & DIVI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Franklin International Core Dividend Tilt Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):